Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)

By Chaudhry Parvesh   Srinivasan Radhika   Patel Firuza  

Cancer Investigation, Vol. 27, Iss. 8, 2009-10 ,pp. : 877-884

Informa Healthcare

Access to resources Recommend Favorite

Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy

By Schilder J.M.   Thompson A.M.   DePriest P.D.   Ueland F.R.   Cibull M.L.   Kryscio R.J.   Modesitt S.C.   Lu K.H.   Geisler J.P.   Higgins R.V.   Magtibay P.M.   Cohn D.E.   Powell M.A.   Chu C.   Stehman F.B.   van Nagell J.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 1-7

Academic Press

Access to resources Recommend Favorite

Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

By Ioannidis Georgios   Souglakos John   Georgoulias Vassilis  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 281-293

Future Medicine

Access to resources Recommend Favorite

Long-term Prognosis Following Macroscopic Complete Response at Second-look Laparotomy in Advanced Ovarian Cancer Patients Treated with Platinum-based Chemotherapy

By Chiara S.   Lionetto R.   Campora E.   Oliva C.   Merlini L.   Bruzzi P.   Rosso R.   Conte P.F.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 296-301

Elsevier

Access to resources Recommend Favorite

Paclitaxel-Anthracycline Combination Chemotherapy in Relapsing Advanced Ovarian Cancer after Platinum-Based Chemotherapy: A Pilot Study

By Kurtz J.E.   Deplanque G.   Duclos B.   Eichler F.   Giron C.   Limacher J.M.   Herbrecht R.   Maloisel F.   Oberling F.   Bergerat J.P.   Dufour P.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 414-417

Elsevier

Access to resources Recommend Favorite